BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3089650)

  • 1. Natural killer activity in patients with acute viral hepatitis.
    Chemello L; Mondelli M; Bortolotti F; Schiavon E; Pontisso P; Alberti A; Rondanelli EG; Realdi G
    Clin Exp Immunol; 1986 Apr; 64(1):59-64. PubMed ID: 3089650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 and natural killer activity in acute type B hepatitis.
    Echevarria S; Casafont F; Miera M; Lozano JL; de la Cruz F; San Miguel G; Pons Romero F
    Hepatogastroenterology; 1991 Aug; 38(4):307-10. PubMed ID: 1937376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E.
    Srivastava R; Aggarwal R; Bhagat MR; Chowdhury A; Naik S
    J Viral Hepat; 2008 Dec; 15(12):910-6. PubMed ID: 18673427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
    Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
    Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer-cell cytotoxicity in HIV-positive and HIV-negative patients with and without severe course of hepatitis B virus infection.
    Morsica G; Tasca S; Biswas P; Galli A; Malnati M; Paties C; Marinelli M; Bagaglio S; Lazzarin A; Fortis C
    Scand J Immunol; 2005 Sep; 62(3):318-24. PubMed ID: 16179020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon responsiveness of natural killer cells in type I human diabetes.
    Negishi K; Gupta S; Chandy KG; Waldeck N; Kershnar A; Buckingham B; Charles MA
    Diabetes Res; 1988 Jan; 7(1):49-52. PubMed ID: 3402165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunologic staging of chronic active hepatitis B patients in Hawaii.
    Ching N; Lumeng J; Pon E; Ching CY
    Hawaii Med J; 1994 Feb; 53(2):44-5, 49. PubMed ID: 7514583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The interferon system and natural cytotoxicity functions in patients with acute viral hepatitis A and B].
    Kaverina OV; Chernova LG; Fabrikov AP; Malinovskaia VV; Kasimova NB; Karpenko SF; Sluvko EI; Cherenova OP
    Ter Arkh; 1994; 66(2):7-9. PubMed ID: 7512755
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission.
    Inada M; Okawa H; Suzuki M; Yata J
    Jpn J Clin Oncol; 1984 Sep; 14(3):335-45. PubMed ID: 6592376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of interferon on clinico-laboratory indicators in patients with acute viral hepatitis B].
    Pokrovskiĭ VI; Zmyzgova AV; Matveeva SM; Saltykov VP; Soibnazarov ISh
    Ter Arkh; 1986; 58(10):29-32. PubMed ID: 3798344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.
    Ghayur T; Seemayer TA; Lapp WS
    Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of hepatitis B virus C protein on function of natural killer cell in NK-92 cells].
    Liu YX; Wei XH; Li B; Luo ZX; Xie JJ; Tan Y; Long SJ; Zhou BP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):275-7. PubMed ID: 19105342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective NK cell activity following thermal injury.
    Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD
    Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressed natural killer cell activity in acute myocardial infarction.
    Klarlund K; Pedersen BK; Theander TG; Andersen V
    Clin Exp Immunol; 1987 Oct; 70(1):209-16. PubMed ID: 3500813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
    Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood T and B cells in patients with acute viral hepatitis A, B and non-A non-B.
    Cargnel A; Rumi MG; Cambieri R; Viganò P; Cancellieri V; Colombo M
    Boll Ist Sieroter Milan; 1982; 61(5):375-82. PubMed ID: 6821443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of interferon-alpha 2 and interleukin-2 on natural killer cell activity in patients with acquired immune deficiency syndrome.
    Reddy MM; Chinoy P; Grieco MH
    J Biol Response Mod; 1984 Aug; 3(4):379-86. PubMed ID: 6332880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS; Hawkins MJ; Borden EC
    Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.